In a pacemaker‑dependent patient with a single‑chamber VVI (ventricular demand) pacemaker undergoing surgery with electrocautery, should a magnet be placed on the device?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Magnet Placement in Pacemaker-Dependent VVI Patients During Surgery

Yes, a magnet should be placed on the pacemaker device in a pacemaker-dependent patient with a VVI pacemaker undergoing surgery with electrocautery above the umbilicus, OR the device should be reprogrammed to asynchronous (VOO) mode—both options are equally acceptable according to the most recent guidelines. 1

The Core Recommendation

The 2024 AHA/ACC/HRS Guideline provides a Class 1, Level B-NR recommendation stating that pacemaker-dependent patients having surgeries above the umbilicus with anticipated electromagnetic interference (EMI) should have the pacemaker either reprogrammed OR have a magnet placed on the generator to provide asynchronous mode and avoid pacing inhibition 1. This gives you two equally valid options.

Why This Matters for Pacemaker-Dependent Patients

In a pacemaker-dependent patient, electrocautery can cause the VVI pacemaker to misinterpret the electrical interference as intrinsic cardiac activity, leading to inappropriate pacing inhibition. Without pacing, these patients have inadequate escape rhythms and will develop profound bradycardia or asystole—a potentially fatal outcome 2.

Converting to asynchronous mode (VOO) ensures the pacemaker delivers fixed-rate ventricular pacing regardless of sensed activity, eliminating the risk of inhibition from EMI 2, 3.

Choosing Between Magnet vs. Reprogramming

Magnet Application is Acceptable When:

  • The magnet response has been confirmed preoperatively by testing it on the device 1
  • Most pacemakers respond to magnets with asynchronous pacing, but some have programmable magnet responses that may be turned off or behave differently 3, 4
  • The magnet must remain securely in place throughout the procedure 5, 6

Reprogramming is Preferred When:

  • There's uncertainty about the magnet response
  • The device is a Biotronik pacemaker in "AUTO" mode (which may only briefly pace asynchronously with magnet application) 4
  • The surgery is prolonged or the magnet position cannot be reliably maintained
  • Leadless pacemakers are present (these require reprogramming, not magnet application) 1

Critical Caveats and Pitfalls

⚠️ Major Warning: The 2024 guideline explicitly states: "Magnets should not be relied on without preoperative confirmation of their effects on CIEDs" 1. Some devices have programmable magnet responses with effects other than forcing asynchronous pacing 1, 3.

Common Errors to Avoid:

  • Never assume a magnet will work without testing it preoperatively 7
  • Magnet application to an ICD does NOT change pacing function—it only affects tachytherapy 3
  • Magnets can accidentally activate from nearby equipment (e.g., PICO wound therapy pumps contain magnets) 8
  • Surgery below the umbilicus typically doesn't require intervention as EMI risk is minimal 1

Intraoperative Management Algorithm

  1. Continuous monitoring: ECG + pulse oximetry (electrocautery obscures ECG, so pulse monitoring is essential) 2, 3, 2

  2. Minimize EMI:

    • Use bipolar electrocautery or ultrasonic scalpel when possible 1, 2
    • If monopolar cautery necessary: short, intermittent bursts at lowest energy 2, 9
    • Position grounding pad to avoid current pathway through the device 2, 9

  3. Have backup ready: External pacing and defibrillation equipment immediately available 2

Postoperative Requirements

Mandatory: Device function must be restored and verified before hospital discharge 1. If reprogrammed preoperatively, restore original settings. If magnet was used, confirm the device has returned to normal sensing mode 3.

The Bottom Line

For your pacemaker-dependent VVI patient: Either place a magnet (after confirming its effect preoperatively) OR reprogram to VOO mode. Both are guideline-supported, Class 1 recommendations. The choice depends on local expertise, device characteristics, and procedural factors. What's non-negotiable is that you must do one or the other to prevent potentially fatal pacing inhibition from electrocautery 1.

References

5
Research

Magnet Use for implantable cardiac devices: A Practical Guide.

Anaesthesia, critical care & pain medicine, 2025

Related Questions

Should a magnet be kept at the bedside for patients with pacemakers, especially those who are pacemaker‑dependent or undergoing surgery with electrocautery?
Why is a magnet required and when should the pacemaker be deactivated in a pregnant patient with long QT syndrome undergoing procedures with monopolar electrocautery?
For a patient with an implanted pacemaker undergoing dental extraction, how should the pacemaker be programmed (including mode changes) and monitored?
What are the recommendations for performing a pacemaker (permanent artificial cardiac pacemaker) ECG with a magnet?
What pacemaker mode should be programmed for a pacing‑dependent patient before an elective surgery that will use monopolar electrocautery near the heart?
Should I discontinue NSAIDs before sacrocolpopexy as directed by my urogynecologist, and what alternative pain management should I use?
What is the perioperative management for a pacemaker‑dependent patient with a single‑chamber VVI (ventricular‑ventricular‑inhibited) pacemaker undergoing surgery?
How should I start and manage Journavx (suvetrigine) therapy, including dose, timing relative to meals, drug interactions, side effects, and alternative pain options?
Is it safe for a patient taking Journavx (suzetrigine) to start pravachol (pravastatin)?
In a benzodiazepine-naïve patient with no history of abuse or early prescription fills who is taking clonazepam 6 mg daily and wishes to continue without tapering, what is the appropriate management?
In a patient presenting to the emergency department with generalized weakness, chest heaviness and dyspnea for 10 hours, hypotension (systolic blood pressure 50 mm Hg), tachycardia (heart rate 137 bpm), tachypnea (respiratory rate 29 breaths/min), temperature 36.5 °C, oxygen saturation 95 %, icterus, basal crackles, ascites, and grade 2 bilateral lower extremity edema, what is the appropriate immediate management and medical treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.